Fed. Circ. Clarifies But Won't Redo AIA On-Sale Bar Ruling
Law360, New York (January 16, 2018, 9:39 PM EST) -- The Federal Circuit on Tuesday said it won’t reconsider invalidating four Helsinn Healthcare SA nausea drug patents in a ruling over the scope of the America Invents Act's on-sale bar, but...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
